…be overcome without comprehensive tools. Running a large-scale clinical study costs around $40 million, and the pharmaceutical industry is losing $50 billion a year on failed clinical trials and ineffective…

Wirano is a new digital platform to help with rapid and effective organisation of clinical trials. The platform aims to revolutionise the activities involved in clinical trials by accelerating start-up…

…access to Catalent’s global network of clinical and commercial manufacturing facilities, and will ensure ongoing optimisation, sustainability and a global reach for the production of ALLOB, as the product heads…

…phase of the project will involve manufacturing of the selected antibody cocktails to support initial clinical trials in 2021, to provide essential safety and efficacy data.        …

…tested in clinical trials for patients with lung cancer, multiple myeloma and other types of solid tumours. Professor Udai Banerji, Deputy Director of Drug Development at The Institute of Cancer…

Bayer has acquired Asklepios BioPharmaceutical (AskBio) a US-headquartered biopharmaceutical company specialising in the research, development and manufacturing of gene therapies across different therapeutic areas. AskBio’s development portfolio includes investigational pre-clinical…

…potential to terminate expensive clinical trials already underway. The new services will incorporate the company’s advanced Liver-on-Chip technology and expertise in the field to enable researchers to generate predictive and…

…eliminate assay development, and standardise assays used for vaccine testing. Heather Tomlinson, PhD, director of clinical diagnostics at Promega Corporation, will discuss how the company used an established, on-market, PCR-based…

…of Qatar in our mRNA vaccine platform and the collaboration we have had to date,” said Stéphane Bancel, Moderna’s Chief Executive Officer. “We are advancing the clinical development of mRNA-1273…

…Institute and Oxford Vaccine Group, began in January 2020. Now undergoing Phase III clinical trials by the University of Oxford and AstraZeneca, the Bristol researchers’ focus was to assess how…